Indegene Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| INDGN.NS | VEEV | 3733.T | 2192.HK | 2158.HK | EVH | |
|---|---|---|---|---|---|---|
| Market cap | 147.71B | 50.29B | 52.33B | 4.90B | 3.04B | 542.68M |
| P/E (TTM) | 36.1 | 50.9 | 10.5 | 12.7 | 37.3 | — |
| Forward P/E | 21.8 | 30.3 | 10.4 | 10.5 | -37.3 | 11.9 |
| Price/book | 4.4 | 6.8 | 1.4 | 0.9 | 0.7 | 1.4 |
| Dividend yield | 0.36% | — | 1.47% | 4.67% | 1.37% | — |
| 1-year change | +16.40% | +6.67% | −17.79% | −36.58% | −48.59% | −20.00% |
| Today | −0.61% | +2.45% | −0.69% | +2.24% | +2.41% | +11.63% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 20 min.
Latest news
All INDGN.NS news ›How Indegene is modernizing and scaling enterprise data quality in life sciences
Migrate to modernize → Modernize to unlock data → unlock data to run AI From startups to enterprises, find AWS solutions scaled to your needs. Access tailored resources, pricing models, and support levels. This post is co-written with…
Indegene Ltd Opens 6.39% Higher in Sharp Gap Up, But Can the Technicals Support It?
Intraday Price Action and Gap Up Dynamics The fact that the intraday fade from the high to the close is notable — does this price action suggest the gap up is vulnerable to a fill or is it a prelude to sustained gains? The session's arc —…
Indegene Limited IPO GMP, Date, Price Band & Review
Indegene Limited IPO GMP Today, Expected Listing Gain & Price Band IndiaIPO Indegene Limited IPO GMP, Date, Price Band & Review Indegene Limited IPO Timeline Verify if your company is ready for IPO Get expert advice for SME listing…
Indegene Reports Strong Q2 FY27; Revenue From Operations Jumps 39.5% To ₹1,122.3 Crore, PAT Up 10%
Mumbai: Indegene Limited on Thursday announced its financial results for the second quarter and half year ended 30 September 2026. The company’s revenue from operations for the quarter stood at ₹1,122.3 crore, marking a 39.5% increase…
Indegene Delivers Strong Q2 FY27 Performance, H1 USD Revenue Growth Reaches a Four-Year High
Indegene, the strategic operating partner to the global life sciences industry, announced its financial results for the quarter ended September 30, 2026. 29 Oct 2026, 08:27 PM IST Equity Bulls All news on Indegene Limited
Indegene Receives Frost & Sullivan's 2026 Global Enabling Technology Leadership Recognition for AI-Powered Pharma Commercialization
/PRNewswire/ -- Frost & Sullivan is pleased to announce that Indegene has received the 2026 Global Enabling Technology Leadership Recognition in pharma... Indegene is recognized for combining domain-led AI, knowledge orchestration, and…
Sensex, Nifty Today LIVE: NSE Stock Market Updates, Oct 15, 2026: Tata Consultancy acquires BBY Services India | Indegene Director Dzialga Resigns Effective 2026
TCS completes acquisition of BBY Services India LLP, making it a wholly owned subsidiary, as per October 15, 2026 filing. Power Mech Projects issues a Rs. 469 crores corporate guarantee for its subsidiary, KTMPL, to secure financing for…
Indegene Digital Summit 2026 Hosts 120+ Pharma Leaders, 19 Speakers, Showcases AI leadership
Mumbai: Indegene Limited hosted its Digital Summit 2026 at the National Constitution Center in Philadelphia, attracting over 120 senior pharma leaders and 19 speakers. The summit focused on artificial intelligence (AI) adoption and…
From the 4Search news index, newest first.
In the news
People in the coverage
Themes
Most coverage from
- businessupturn.com2
- freepressjournal.in2
- prnewswire.com2
- equitybulls.com1
- indiaipo.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.